Bartels, John R., Jr., administrator, Drug Enforcement Administration,
U.S. Department of Justice.-
Beaver, Dr. William T., associate professor of Pharmacology and Anesthe-
siology, Georgetown University School of Medicine___
Cochin, Dr. Joseph, professor of Pharmacology and Psychiatry, Boston
University School of Medicine_
DuPont, Dr. Robert L., director, White House Special Action Office for
Drug Abuse Prevention.--.
Harris, Dr. Louis, professor and chairman, Department of Pharmacology,
Medical College of Virginia, Virginia Commonwealth University----
Jaffe, Dr. Jerome H., professor of Psychiatry, Columbia University College
of Physicians and Surgeons; chief of Psychiatric Research, New York
State Psychiatric Institute; and, former director, White House Special
Action Office for Drug Abuse and Prevention..
Jennings, Dr. John, associate commissioner for Medical Affairs, Food and
Drug Administration---
Johnson, Edward E., chairman, Opium Policy Task Force; and, special
assistant to the Deputy Director, Office of Management and Budget----
Jones, Arnold, General Accounting Office----
Jones, Dr. Quentin, Agricultural Research Service, U.S. Department of
Agriculture
Kennedy, Dr. Stephen, Drug Abuse staff, Bureau of Drugs, Food and Drug
Administration
Lowe, Victor L., director, General Government Division, General Account-
ing Office---
McGrew, Jane Lang, attorney, Steptoe & Johnson_-_-
Minnick, Walter, former chief, Federal Drug Management Division, Office
of Management and Budget-.
Scoville, Dr. Barrett, director, Division of Neuropharmacological Drug
Products, Bureau of Drugs, Food and Drug Administration__
Stanton Dan, associate director, General Accounting Office-
NOTE. Cited materials may be found in the files of the Subcommittee To Investigate
Juvenile Delinquency, Committee on the Judiciary, United States Senate.
CHRONOLOGICAL LIST OF WITNESSES
TUESDAY, MARCH 4, 1975
DuPont, Dr. Robert L., director, White House Special Action Office for
Drug Abuse Prevention----
Vance, Hon. Sheldon B., senior adviser to the Secretary of State for Inter-
national Narcotics Matters; and, executive director, Cabinet Committee
on International Narcotics Control__.
Bartels, John R., Jr., administrator, Drug Enforcement Administration.
U.S. Department of Justice-----
Table 1-Codeine consumption, 1969-1973_.
Table 2-Manufacture of morphine, 1966–1974_.
HEW response of January 14, 1975, reestimates drug requirements__
Letter of December 8, 1975, with enclosures of analysis of difference
between fiscal year 1976 Drug Enforcement Administration request
and OMB congressional submission.......
Johnson, Edward E., chairman, Opium Policy Task Force; and, special
assistant to the Deputy Director, Office of Management and Budget____
1. Letter of request to Mr. Walter Minnick to appear as witness at hear-
ings on the cultivation, use and control of opium, from Senator
Birch Bayh, chairman_
2. Testimony of Walter C. Minnick, chief, Division of Federal Drug
Management, Office of Management and Budget before the Special
Studies Subcommittee of the Committee on Government Opera-
tions, U.S. House of Representatives, May 10, 1973 on Evaluating
the Federal Effort To Control Drug Abuse (Part I) . ____
3. Letter of request to Hon. Earl L. Butz, Secretary of Agriculture, to
appear as witness at hearings on the cultivation, use and control of
opium, from Senator Birch Bayh, chairman__
4. Response of Mallinckrodt, Inc., of April 21, 1975, for additional in-
formation requested at hearing of March 4, 1975.
Letter of March 18, 1976, to John M. Rector, Staff Director and
Chief Counsel, U.S. Senate Subcommittee To Investigate Juvenile
Delinquency, from Burroughs Wellcome Co., with data of a 10-year
comparison of the prescription use of all potent analgesics.-
6. Letter of May 11, 1976 to Hon. Birch Bayh from Jane McGrew of
Steptoe & Johnson with enclosures on the subject of bracteatum___.
Cultivation of Papaver Bracteatum in the United States, March 10,
1976...
Cultivation of Papaver Bracteatum in the United States, May 1976---
The Feasibility of the Conversion of Thebaine into Drugs of Abuse and
of Potential Abuse, United Nations Narcotics Laboratory, Geneva,
26-30, January 1976....
7. Excerpts from hearings before the U.S. Senate Subcommittee To
Investigate Juvenile Delinquency on Narcotics Legislation, pp. 352-
74, testimony of Stephen Ailes, representing S. B. Penick & Co.,
Merck & Co., and Mallinckrodt Chemical Works.-
NOTE. Cited materials may be found in the files of the Subcommittee To Investigate
Juvenile Delinquency, Committee on the Judiciary, United States Senate.
8. Response of S. B. Penick & Co., of May 30, 1975, for additional in-
formation requested at hearing of March 4, 1975.
Response of Merck & Co., Inc., of June 2, 1975, for additional in-
formation requested at hearing of March 4, 1975..
9. Letter of November 26, 1975 to John M. Rector, Staff Director and
Chief Counsel, U.S. Senate Subcommittee To Investigate Juvenile
Delinquency, from Jane McGrew of Steptoe & Johnson with en-
closure on subject of domestic cultivation of papaver bracteatum. __
Issues in the Use of Papaver Bracteatum, by Peter G. Bourne, M.D.,
Foundation for International Resources, October 1975.
Letter to Jane McGrew, Esq., Steptoe and Johnson, from John M.
Rector, Staff Director and Chief Counsel of the Subcommittee To
Investigate Juvenile Delinquency, regarding assistance of Dr. Peter
Bourne on papaver bracteatum and other related issues---.
10. Letter of request to Dr. Robert L. DuPont, director, Special Action
Office for Drug Abuse Prevention, to appear as witness at hearings
on the cultivation, use and control of opium, from Senator Birch
Bayh, chairman....
Letter of request to Dr. Everette May, chief, Section on Medical
Chemistry, National Institute of Health, to appear as witness at
hearings on the cultivation, use and control of opium, from Senator
Birch Bayh, chairman..
Letter of request to Hon. Casper W. Weinberger, Secretary of Health,
Education, and Welfare, to appear as witness at hearings on the
cultivation, use and control of opium, from Senator Birch Bayh,
chairman..
11. Excerpt from Federal Strategy for Drug Abuse and Drug Traffic
Prevention 1974, pp. iii, 60-67-
Excerpt from White Paper on Drug Abuse, September 1975, pp. iii,
54-56---
12. Excerpt from Message From the President to the Congress on His
Omnibus Drug Control Legislation, June 17, 1971, pp. 115-117-----
13. Article: DuPont cites Public Apathy as Obstacle in Anti-Drug
Efforts, from the Narcotics Control Digest, March 12, 1975....
14. Excerpt from Public Law 92-255: The Drug Abuse Office and Treat-
ment Act of 1972, pp. 1, 6–7..
15. Heroin, January 1975, from the National Clearinghouse for Drug
Abuse Information, DHEW Pub. No. (ADM) 75–81...
16. Excerpt from Conference Report of March 17, 1972, on the Drug
Abuse Office and Treatment Act of 1972, pp. 1, 7, 8, and 27.
17. Excerpt from Conference Report of February 19, 1976, on the Drug
Abuse Office and Treatment Act Amendments of 1976, pp. 1 and 4...
18. An Assessment of the Diffusion of Heroin Abuse to Medium-Sized
American Cities, October 1974, Special Action Office for Drug
Abuse Prevention, Executive Office of the President...
19. Letter of request to Hon. Henry A. Kissinger, Secretary of State,
to appear as witness at hearings on the cultivation, use and control
of opium, from Senator Birch Bayh, chairman; with response from
Ambassador Sheldon B. Vance..
20. The Diplomatic War on Heroin: A Southeast Asian Success Story,
case study by Clyde McAvoy, 17th session, Senior Seminar in
Foreign Policy, Department of State, 1974-75.
21. International Narcotics Control: A High-Priority Program, address
by Sheldon B. Vance, from Department of State Bulletin, Jan-
uary 27, 1975__.
22. Revised Turkish Poppy Cultivation System, Department of State
Press Release, September 20, 1974---
NOTE. Cited materials may be found in the files of the Subcommittee To Investigate
Juvenile Delinquency, Committee on the Judiciary, United States Senate.
25. Letter of request to Hon. Edward H. Levi, Attorney General of the
United States, to appear as witness at hearings on the cultivation,
use and control of opium, from Senator Birch Bayh, chairman;
with response from the Acting Assistant Attorney General desig-
nating John R. Bartels, administrator, DEA, to present the Depart-
ment's testimony..
26. Letter of March 1, 1976, to Hon. Birch Bayh from Peter B. Bensinger,
administrator, DEA, Department of Justice, regarding inter-
national drug trafficking, with enclosure. -
A Review of the Illicit Drug Traffic, by John T. Cusack, at the
4th Special Session of the U.N. Commission on Narcotic Drugs,
Geneva, February 24, 1976___.
27. Statement of John R. Bartels, Jr., administrator, DEA, Department
of Justice, and Dr. Robert L. DuPont, director, Special Action
Office for Drug Abuse Prevention, before the Subcommittee on
Future Foreign Policy and Development, House Committee on In-
ternational Relations, April 23, 1975.
28. Need To Control Illicit Opiate Diversion vs. Need for Medicinal
Codeine, an unpublished GAO Report on DEA document, Volume
I: World Requirements of Opiates_
29. Article: Fund for Crime-Fighting Lower After an Allowance for
Inflation, by Nicholas M. Horrock, from the New York Times,
February 4, 1975.
30. Statement of Jerry N. Jenson, deputy administrator, DEA, Depart-
ment of Justice, before the Subcommittee on Future Foreign Policy
Research and Development, House International Relations
Committee, July 28, 1975--
31. 1975-A Year of Crisis, by John R. Bartels, Jr., from the Police Chief,
February 1975.
32. Appendixes: Background Material on Opium Production and Narcotic
Abuse Statistics..
33. Letter of request to James T. Lynn, director, Office of Management
and Budget, to appear as witness at hearings on the cultivation,
use and control of opium, from Senator Birch Bayh, chairman;
with response from the director designating Edward E. Johnson to
present testimony for the OMB..
34. Letter of October 26, 1976, to John M. Rector from Edward E.
Johnson, chairman, Opium Policy Task Force, OMB, with enclosure
regarding the U.S. statement on Agenda Item 5: The world's
requirements of codeine for medical and scientific purposes, and the
position in regards to its supply, as given February 19, 1976...
35. Letter of November 5, 1976, to John M. Rector from Edward E.
Johnson, chairman, Opium Policy Task Force, OMB, regarding
developments of the supply of opium-derived drugs for medical and
scientific use_--
PART 1-INTERNATIONAL PRODUCTION AND CONTROL OF OPIATES
U.N. Commission on Narcotic Drugs Holds Special Session, information
letter, No. 9, September 1976.
Review of the 25th Session of the Commission on Narcotic Drugs, from
U.N. Bulletin on Narcotics, Vol. XXV, No. 2, April-June 1973..
Third Special Session of the Commission on Narcotic Drugs, from U.N.
Bulletin on Narcotics, Vol. XXVI, No. 2, April-June 1974.
+NOTE. Cited materials may be found in the files of the Subcommittee To Investigate
Juvenile Delinquency, Committee on the Judiciary, United States Senate.
|